Effects of Telmisartan Compared With Candesartan on Ischemic Cardiovascular Events in High-Risk Hypertensive Patients: a Multi-Center, Prospective, Randomized, Open-Labeled, Blinded Endpoints Trial

Trial Profile

Effects of Telmisartan Compared With Candesartan on Ischemic Cardiovascular Events in High-Risk Hypertensive Patients: a Multi-Center, Prospective, Randomized, Open-Labeled, Blinded Endpoints Trial

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 07 Sep 2015

At a glance

  • Drugs Candesartan cilexetil (Primary) ; Telmisartan (Primary)
  • Indications Hypertension; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms KCPS
  • Most Recent Events

    • 29 Mar 2012 Planned End Date changed from 1 Mar 2014 to 1 Dec 2014 as reported by University Hospital Medical Information Network - Japan record.
    • 22 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 05 Aug 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top